Dual role of microRNA-31 in human cancers; focusing on cancer pathogenesis and signaling pathways

Exp Cell Res. 2024 Oct 1;442(2):114236. doi: 10.1016/j.yexcr.2024.114236. Epub 2024 Sep 6.

Abstract

Widespread changes in the expression of microRNAs in cancer result in abnormal gene expression for the miRNAs that control those genes, which in turn causes changes to entire molecular networks and pathways. The frequently altered miR-31, which is found in a wide range of cancers, is one cancer-related miRNA that is particularly intriguing. MiR-31 has a very complicated set of biological functions, and depending on the type of tumor, it may act both as a tumor suppressor and an oncogene. The endogenous expression levels of miR-31 appear to be a key determinant of the phenotype brought on by aberrant expression. Varied expression levels of miR-31 could affect cell growth, metastasis, drug resistance, and other process by several mechanisms like targeting BRCA1-associated protein-1 (BAP1), large tumor suppressor kinase 1 (LATS1) and protein phosphatase 2 (PP2A). This review highlights the current understanding of the genes that miR-31 targets while summarizing the complex expression patterns of miR-31 in human cancers and the diverse phenotypes brought on by altered miR-31 expression.

Keywords: Cancer; Drug resistance; Pathogenesis; Signaling pathways; miR-31; miRNAs.

Publication types

  • Review

MeSH terms

  • Animals
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Signal Transduction* / genetics

Substances

  • MicroRNAs
  • MIRN31 microRNA, human